SWN
30
-12
CVX
23
-2
WFC
58
-3
SNA
53
-3
AVB
72
3
AA
38
3
CB
58
-2
K
30
-2
COST
69
-4
MCHP
52
3
DHR
50
4
TRV
43
-3
HRL
29
2
HSIC
44
4
MRK
66
3
AMP
73
-2
CRM
59
4
SLB
48
2
ZTS
49
20
AIZ
64
-2
SWN
30
-12
CVX
23
-2
WFC
58
-3
SNA
53
-3
AVB
72
3
AA
38
3
CB
58
-2
K
30
-2
COST
69
-4
MCHP
52
3
DHR
50
4
TRV
43
-3
HRL
29
2
HSIC
44
4
MRK
66
3
AMP
73
-2
CRM
59
4
SLB
48
2
ZTS
49
20
AIZ
64
-2
Financhill
Back

Lennox International Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
87

LII
Lennox International

Last Price:
543.00
Seasonality Move:
4.05%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
87
Lennox International (LII) is a Buy

Is Lennox International a Buy, Sell or Hold?

  • The current Lennox International [LII] share price is $543.00. The Score for LII is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • LII is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LII Stock Price Chart

What is Lennox International's stock price today?

  • The Lennox International share price today is $543.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LII is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LII Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.57 Buy
Relative Strength Index (14 RSI): 65.79 Buy
Chaikin Money Flow: 408930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (487.66 - 529.54) Buy
Bollinger Bands (100): (451.16 - 503.62) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

LII Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 536.36 Buy
20-day SMA: 512.56 Buy
50-day SMA: 490.11 Buy
200-day SMA: 440.03 Buy
8-day EMA: 535.02 Buy
20-day EMA: 518.15 Buy
50-day EMA: 498.29 Buy
200-day EMA: 441.49 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Lennox International Earnings Growth & LII Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.16 per share, a decrease next quarter of $1.86 per share, an increase this year of $2.17 per share, and an increase next year of $2.60 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Lennox International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):